HHealth Read More UCLA presents advances in radiation therapy at ASTRO 2025September 27, 2025 Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
HHealth Read More Novel treatment disrupts tumor immunosuppression in pancreatic cancerSeptember 27, 2025 Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University…
HHealthcare Read More Philips new CT and MR systems at ASTRO 2025September 27, 2025 Philips expands MR leadership with helium-free BlueSeal RT [4] Alongside its newest CT innovations, Philips is introducing…
HHealth Read More Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States | Breast Cancer ResearchSeptember 26, 2025 Data source and study participants To examine the trend in death rate from DCIS among women, we used…
BBusiness Read More Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025September 26, 2025 Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety…
HHealth Read More “Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood CancersSeptember 26, 2025 Researchers at King’s College London have uncovered a surprising vulnerability in certain blood cancers by targeting a part…
MMedication Read More Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm – politico.euSeptember 23, 2025 Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm politico.euWhat Trends Are You Seeing in Pharma Commercialization? PharmExecIreland faces…
HHealth Read More Regular mammograms linked to longer survival in women over 80September 22, 2025 For many older women, the question of whether to continue breast cancer screening has been uncertain. While most…
SScience Read More Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC CancerSeptember 20, 2025 Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
HHealth Read More Preventing radiation damage with melanin-based materialSeptember 19, 2025 Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
HHealth Read More Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumorsSeptember 19, 2025 A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos…
BBusiness Read More Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatmentSeptember 18, 2025 Establishment of the TIME subtype According to recent literature, knowledge of the TIME should be the main emphasis…